DEMGY Group, an international technology group specializing in innovative plastics processing, produces high-precision medical devices using high-performance materials. With 4 ISO 13485 medically certified manufacturing sites in France and the USA, 3 R&D centers and 4 ISO 7 & 8 cleanrooms, DEMGY supports its customers from eco-design to the manufacture, assembly and packaging of new medical devices.

Presentation of innovative "microfluidic" technology for lab-on-a-chip production using micro-injection molding.

DEMGY has the capacity to industrialize the manufacture of customized microfluidic devices: lab-on-a-chip, biochips, mTas, microfluidic cartridges... They all feature a combination of characteristics, microstructures linked by microchannels to fulfill an analytical function.

Miniature features measuring just a few microns can be integrated into the cartridge - reservoirs, micro-pillars, valves - to enable functions such as sample splitting, spacing or mixing.

Microfluidic plates manufactured by DEMGY can be connected, fitted with through-holes and even interact with other devices by equipping the chip with an integrated sensor to measure pH or temperature, for example.

Medical devices are injected and assembled in clean rooms

DEMGY is equipped with 4 state-of-the-art ISO 7 and ISO 8 cleanrooms, in which medical devices are injection molded and assembled.

About DEMGY :

Founded in 1947, DEMGY Group, an international technology group in innovative plastics processing, designs and manufactures high-performance plastic and composite solutions that are lighter than metal, to promote energy savings. DEMGY Group is actively involved in the process of decarbonizing industry.

Its circular Multiplasturgy® offering, a one-stop shop for its 15 areas of expertise, starts with eco-design, which enables upstream management of the end-of-life of products and their recyclability.

The Group has 5 sites in France, 2 in Germany, 2 in Romania and 1 in the United States, as well as 3 R&D centers and 2 sales offices in the UK and Israel.

In 2023, DEMGY Group generated sales of 100 million euros, 7% of which was invested in R&D and capital expenditure.

DEMGY Group employs over 800 people.

Contact:

Mike Walter
Division President of DEMGY Chicago 
m.walter@demgy.com

 

Source:prnewswire.com

Report Abuse